As Allergan, an AbbVie Company, we've been creating innovative
products and services for our patients for over 70 years and we
continue to push the boundaries of what’s possible in eye care each
and every day. When Gavin S. Herbert founded the first antihistamine
eye drop, he ignited an enduring spirit of innovation and a passion
for finding solutions that preserve vision. From the very early days,
Herbert understood the importance of working with front-line eye care
professionals to identify the products that result in the best
outcomes for patients.
Since then our eye care products have helped manage and preserve the
vision of millions of people worldwide.
In May 2020, AbbVie acquired Allergan and together as one combined
team we understand the importance of sight and that any loss of vision
can have a devastating impact on peoples’ lives. This is why we
continue to search for new treatments that address unmet needs and new
approaches to help preserve and protect our patients' vision.
Today, we have a global reputation for innovation in:
- Ocular surface disease